Bavarian Nordic may well upgrade again, says Sydbank analyst

The US government’s order of Bavarian Nordic’s monkeypox vaccine will not be the last, says Sydbank senior analyst Søren Løntoft Hansen.

Photo: Christinne Muschi/REUTERS / X01320

On Friday, June 10, Bavarian Nordic upgraded its financial guidance for 2022 for the third time in three weeks.

Following monkeypox outbreaks all over the world, governments are on the hunt for vaccines, leading to an order boost for Bavarian Nordic.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs